Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SURE DENMARK/SWEDEN: A Multi-centre, Prospective, Non-interventional Study Investigating the Effectiveness of Once-weekly Subcutaneous Semaglutide in a Real World Adult Population With Type 2 Diabetes

NCT03648281 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03648281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03648281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SURE DENMARK/SWEDEN: A Multi-centre, Prospective, Non-interventional Study Investigating the Effectiveness of Once-weekly Subcutaneous Semaglutide in a Real World Adult Population With Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
August 24, 2018
Completion date
January 10, 2020
Enrollment
333 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2